BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 21439354)

  • 21. Neurosteroids, neuroactive steroids, and symptoms of affective disorders.
    Dubrovsky B
    Pharmacol Biochem Behav; 2006 Aug; 84(4):644-55. PubMed ID: 16962651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of the neuroactive steroid 5beta-pregnane-3beta, 20(R)-diol on the time course of GABA evoked currents is different to that of pregnenolone sulphate.
    Strömberg J; Lundgren P; Taube M; Bäckström T; Wang M; Haage D
    Eur J Pharmacol; 2009 Mar; 605(1-3):78-86. PubMed ID: 19168059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticipation and consumption of food each increase the concentration of neuroactive steroids in rat brain and plasma.
    Pisu MG; Floris I; Maciocco E; Serra M; Biggio G
    Pharmacol Biochem Behav; 2006 Sep; 85(1):76-81. PubMed ID: 16938341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine.
    Serra M; Pisul MG; Dazzi L; Purdy RH; Biggio G
    J Psychopharmacol; 2002 Jun; 16(2):133-8. PubMed ID: 12095071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroactive steroids in responders and nonresponders to sleep deprivation.
    Schüle C; Di Michele F; Baghai T; Romeo E; Bernardi G; Zwanzger P; Padberg F; Pasini A; Rupprecht R
    Ann N Y Acad Sci; 2004 Dec; 1032():216-23. PubMed ID: 15677414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research.
    Porcu P; Barron AM; Frye CA; Walf AA; Yang SY; He XY; Morrow AL; Panzica GC; Melcangi RC
    J Neuroendocrinol; 2016 Feb; 28(2):12351. PubMed ID: 26681259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal exposure to estradiol in rats influences neuroactive steroid concentrations, GABAA receptor expression, and behavioral sensitivity to anxiolytic drugs.
    Calza A; Sogliano C; Santoru F; Marra C; Angioni MM; Mostallino MC; Biggio G; Concas A
    J Neurochem; 2010 Jun; 113(5):1285-95. PubMed ID: 20345753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroactive steroids.
    Paul SM; Purdy RH
    FASEB J; 1992 Mar; 6(6):2311-22. PubMed ID: 1347506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroactive steroid actions at the GABAA receptor.
    Lan NC; Gee KW
    Horm Behav; 1994 Dec; 28(4):537-44. PubMed ID: 7729823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.
    Nothdurfter C; Baghai TC; Schüle C; Rupprecht R
    Eur Arch Psychiatry Clin Neurosci; 2012 Nov; 262 Suppl 2():S107-12. PubMed ID: 22923187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment.
    Ströhle A; Romeo E; di Michele F; Pasini A; Yassouridis A; Holsboer F; Rupprecht R
    Am J Psychiatry; 2002 Jan; 159(1):145-7. PubMed ID: 11772707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options.
    Rupprecht R; Pradhan AK; Kufner M; Brunner LM; Nothdurfter C; Wein S; Schwarzbach J; Puig X; Rupprecht C; Rammes G
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1477-1487. PubMed ID: 36574032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression.
    Padberg F; di Michele F; Zwanzger P; Romeo E; Bernardi G; Schüle C; Baghai TC; Ella R; Pasini A; Rupprecht R
    Neuropsychopharmacology; 2002 Nov; 27(5):874-8. PubMed ID: 12431862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3alpha,5alpha-tetrahydrodeoxycorticosterone concentrations.
    Zwanzger P; Eser D; Romeo E; di Michele F; Baghai TC; Pasini A; Padberg F; Rupprecht R
    Psychoneuroendocrinology; 2009 Nov; 34(10):1586-9. PubMed ID: 19501468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam.
    Gasior M; Carter RB; Goldberg SR; Witkin JM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):543-53. PubMed ID: 9262314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons.
    Bäckström T; Haage D; Löfgren M; Johansson IM; Strömberg J; Nyberg S; Andréen L; Ossewaarde L; van Wingen GA; Turkmen S; Bengtsson SK
    Neuroscience; 2011 Sep; 191():46-54. PubMed ID: 21600269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders?
    Rupprecht R; Wetzel CH; Dorostkar M; Herms J; Albert NL; Schwarzbach J; Schumacher M; Neumann ID
    Mol Psychiatry; 2022 Jul; 27(7):2918-2926. PubMed ID: 35444254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results.
    Ströhle A; Romeo E; di Michele F; Pasini A; Hermann B; Gajewsky G; Holsboer F; Rupprecht R
    Arch Gen Psychiatry; 2003 Feb; 60(2):161-8. PubMed ID: 12578433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis.
    Luchetti S; Huitinga I; Swaab DF
    Neuroscience; 2011 Sep; 191():6-21. PubMed ID: 21514366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.